Achievements and obstacles of remyelinating therapies in multiple sclerosis
Martin Stangel, Tanja Kuhlmann, Paul M Matthews, Trevor J Kilpatrick
Nature Reviews Neurology | NATURE PUBLISHING GROUP | Published : 2017
Awarded by German Research Foundation
Awarded by Interdisciplinary Clinical Research Center, Munster (IZKF)
This study was supported by grants to T.K. from the German Research Foundation (SFB-TR128-B7; Ku1477/6-1) and the Interdisciplinary Clinical Research Center, Munster (IZKF; KuT3/012/15). P.M.M. is in receipt of personal and research support from the Edmond J. Safra Foundation and Lily Safra, the Imperial College National Institute for Health Research (NIHR) Biomedical Research Centre, the NIHR Senior Investigator Programme, the UK Dementia Research Institute, the UK Medical Research Council, Biogen and the Engineering and Physics Science Research Council. M.S. is supported by Niedersachsen Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony.